Short description
PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.
Description
PolyProx Therapeutics is developer of a novel class of drug intended to provide new therapies for cancer treatment. The company's drug will use novel engineered protein that is able to selectively target tumour cells and trigger natural degradation machinery within the cell, enabling cancer patients to benefit from the treatment that targets and remove disease-causing proteins.
Last funding
Cannot Access
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Cambridge, Cambridgeshire, United Kingdom, Europe
Founded on
January 1, 2019
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$34056 - 789030
Sign in for full access
Investors
Uh Ohhhh, Noaccess, Noway Youcantaccess, Absolutely Noaccess, Noaccess, Blurry Noaccess
Sign in for full access
Founders
Laura S Itzhaki